SCHEMBL7404189

SCHEMBL7404189

O=C(c1ccncc1)c1ccccc1F

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.59
MEN1 O00255 2/20 0.59
HTT P42858 2/20 0.57
LTA4H P09960 1/20 0.55
RAB9A P51151 2/20 0.53
CES2 O00748 1/20 0.52
CES1 P23141 1/20 0.52
MAPK7 Q13164 1/20 0.51
MAPK14 Q16539 1/20 0.51
ALDH1A1 P00352 4/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
VNN1 O95497 1/20 0.49
GAA P10253 1/20 0.48
ALOX15 P16050 1/20 0.48
CDK5 Q00535 1/20 0.48
CDK5R1 Q15078 1/20 0.48
POLB P06746 2/20 0.48
LMNA P02545 2/20 0.46
ABCC9 O60706 1/20 0.46
ABCC8 Q09428 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10759830 0.86 CES2 (0.62) KMT2AMEN1RAB9ACES2CES1
SCHEMBL333008 0.84 AKR1C3 (0.61) KMT2AMEN1RAB9ACES2CES1
SCHEMBL29433447 0.84 AKR1C3 (0.61) KMT2AMEN1RAB9ACES2CES1
SCHEMBL9507199 0.80 CDC25B (0.60) KMT2AMEN1RAB9ACES2CES1
SCHEMBL29377967 0.80 CES2 (0.56) KMT2AMEN1HTTLTA4HRAB9A
SCHEMBL896769 0.80 CES2 (0.56) KMT2AMEN1HTTLTA4HRAB9A
SCHEMBL28819050 0.79 L3MBTL1 (0.67) HTTRAB9AALDH1A1SMN1; SMN2POLB
SCHEMBL250099 0.79 CES2 (0.71) KMT2AMEN1HTTCES2CES1
SCHEMBL30293901 0.79 CES2 (0.71) KMT2AMEN1HTTCES2CES1
SCHEMBL24567097 0.78 LIG1 (0.66) KMT2AMEN1HTTLTA4HRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6124323-A ACTIVE DRUG TREATING STROKE, CEREBRAL ISCHEMIA, CENTRAL NERVOUS SYSTEM TRAUMA, HYPOGLYCEMIA, ANXIETY, CONVULSIONS, AMIOGLYCOSIDE ANTIBIOTICS-INDUCED HEARING LOSS, MIGRAINE HEADACHES, CHRONIC PAIN, GLAUCOMA, CMV RETINITIS, PSYCHOSIS WARNER-LAMBERT COMPANY (US) 2000-09-26 US disclosed
EP-0869792-A4 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER LAMBERT CO (US) 1999-09-22 EP disclosed
EP-0869792-A2 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1998-10-14 EP disclosed
WO-1997023216-A1 4-SUBSTITUTED PIPERIDINE ANALOGS AND THEIR USE AS SUBTYPE SELECTIVE NMDA RECEPTOR ANTAGONISTS WARNER-LAMBERT COMPANY (US) 1997-07-03 WO disclosed